ArticleCellular and molecular neurobiology2026
Nyap1 Redirects JNK Signaling to Couple Neuroprotection with Circuit Regeneration After Spinal Cord Injury.
Article in Cellular and molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mitochondrial Crossroads in Neurobiology: From Cellular Vulnerability to Therapeutic Opportunity.Cellular and molecular neurobiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Spinal cord injury (SCI) causes permanent motor deficits primarily due to neuronal apoptosis and inadequate axonal regeneration, with the c-Jun N-terminal kinase (JNK)/c-Jun pathway playing a dual role in neurodegeneration and regeneration. Here, we identified Nyap1 as a spatiotemporally limited modulator that rearranges JNK signaling to shift its function from degeneration to regeneration. Time-resolved transcriptomic profiling showed Nyap1 was dynamically upregulated as a hub gene during the acute-to-subacute phase of SCI. Nyap1 was associated with altered subcellular distribution of p-JNK, with increased cytoplasmic retention, with overexpression enriching p-JNK in the cytosol and limiting nuclear translocation-sufficient to drive regenerative transcription without inducing apoptosis. This interaction was associated with modulation of apoptosis-related and regeneration-related signaling, including changes in the Bcl-2/Bax ratio, caspase-3 activation, c-Jun phosphorylation, and GAP43 expression, with these effects abrogated by JNK inhibition. In vivo, Nyap1 overexpression preserved thoracic spinal motor neurons, promoted descending propriospinal tract (DPST) axonal regeneration, enhanced lumbar motor neuron dendritic arborization and synaptic input, and reduced lesion cavity volume. These structural improvements were accompanied by better gait coordination, neuromuscular reinnervation, and translesional motor conduction. Our findings support a model in which Nyap1 is associated with spatial redistribution of p-JNK-related signaling, linking neuronal survival with circuit-level plasticity after SCI, highlighting its potential as a therapeutic candidate for CNS trauma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.